Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-4690

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment ; volume:9 ; number:1 ; day:25 ; month:5 ; year:2012 ; pages:1 ; date:12.2012
Retrovirology ; 9, Heft 1 (25.5.2012), 1, 12.2012

Creator: Menard, Amélie

Contributor: Brunet, Corinne
Obry, Véronique
Dukan, Patrick
Bregigeon, Sylvie
Faucher, Olivia
Balducci, Estelle
Ritleng, Anne-Suzel
Dignat-George, Françoise
Martin, Isabelle Poizot
SpringerLink (Online service)

DOI: 10.1186/1742-4690-9-S1-P56

URN: urn:nbn:de:1111-2016080723968

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Menard, Amélie
Brunet, Corinne
Obry, Véronique
Dukan, Patrick
Bregigeon, Sylvie
Faucher, Olivia
Balducci, Estelle
Ritleng, Anne-Suzel
Dignat-George, Françoise
Martin, Isabelle Poizot
SpringerLink (Online service)

Other Objects (12)

Rapid virological response is the best predictor for achieving SVR under peg-IFN/ribavirin hepatitis C therapy in HIV/HCV co-infected patients

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Rapid virological response is the best predictor for achieving SVR under peg-IFN/ribavirin hepatitis C therapy in HIV/HCV co-infected patients

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Rapid virological response is the best predictor for achieving SVR under peg-IFN/ribavirin hepatitis C therapy in HIV/HCV co-infected patients

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Rapid virological response is the best predictor for achieving SVR under peg-IFN/ribavirin hepatitis C therapy in HIV/HCV co-infected patients

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Rapid virological response is the best predictor for achieving SVR under peg-IFN/ribavirin hepatitis C therapy in HIV/HCV co-infected patients

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Rapid virological response is the best predictor for achieving SVR under peg-IFN/ribavirin hepatitis C therapy in HIV/HCV co-infected patients

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HCV relapse after peg-interferon (IFN) plus ribavirin (RBV) therapy: is 12-week follow-up enough to determine sustained HCV clearance?

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

Hepatitis C treatment initiation in HIV-HCV coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV

Hospitalizations and deaths among people coinfected with HIV and HCV

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Related objects

Reset password